SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A Co-Founder sold $903k worth of stock under a pre-arranged 10b5-1 trading plan, representing a very small fraction of their holdings and the company's market capitalization.
• Market Impact: Neutral. The transaction is not material and was pre-scheduled, suggesting it is for personal financial planning rather than a reaction to company events.

Company Information

Field	Value
Company	Natera, Inc.
Ticker Symbol	NTRA
CIK	0001604821
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Sheena Jonathan
CIK	0001646649
Title/Position	CO-FOUNDER
Relationship	Director, Other

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-07 and 2025-11-11
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	4,570
Avg. Price Per Share	$197.61 (Weighted Average)
Total Value	$903,093.05
Shares Owned After	283,224 (Direct & Indirect)
Ownership Type	Direct & Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$903,093.05
% of Market Cap	0.0033%
Shares Transacted	4,570
% of Shares Outstanding	0.0033%
Post-Transaction Ownership	283,224 shares (0.21% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of approximately $903k is negligible for a large-cap company with a market capitalization of $27.45 billion.
• Ownership Concentration: The sale represented only about 1.6% of the insider's total holdings, indicating it was not a significant liquidation of their position. The insider's post-transaction ownership of 0.21% is not a controlling stake.
• Transaction Significance: Based on the thresholds, the transaction's value as a percentage of market cap (0.0033%) and shares as a percentage of outstanding (0.0033%) are both well below the 0.1% level for low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is immaterial relative to the company's size and was executed under a Rule 10b5-1 plan. Such pre-scheduled trades are common for executive financial management and do not typically influence market sentiment.

Volume & Sentiment

• Expected Volume Impact: Negligible. The number of shares sold is a tiny fraction of typical daily trading volume for NTRA.
• Sentiment Indicator: Neutral. The pre-scheduled nature of the sale via a 10b5-1 plan mitigates any negative sentiment that might arise from an insider sale.

Additional Context

Special Circumstances

• The filing footnotes explicitly state that all sales were made pursuant to Rule 10b5-1 trading plans adopted in June 2024 and December 2024. This indicates the transactions were planned far in advance.